Loading clinical trials...
Loading clinical trials...
Multi-center, Prospective, Randomized, Placebo-Controlled, Delayed Treatment, Double-Blind Study to Evaluate the Effectiveness and Safety of a Single Oral Dose of Solosec® for the Treatment of Trichomoniasis
Conditions
Interventions
Secnidazole
Placebo
Locations
11
United States
Site 1007
Birmingham, Alabama, United States
Site 1003
North Miami, Florida, United States
Site 1014
Chicago, Illinois, United States
Site 1013
Jackson, Mississippi, United States
Site 1009
Lawrenceville, New Jersey, United States
Site 1008
Chapel Hill, North Carolina, United States
Start Date
April 23, 2019
Primary Completion Date
March 2, 2020
Completion Date
March 25, 2020
Last Updated
October 4, 2023
Lead Sponsor
Lupin Research Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions